Wellington Shields & Co. LLC Cuts Stock Holdings in Albemarle Corporation $ALB

Posted by Francis Steltz on May 27th, 2026

Wellington Shields & Co. LLC lowered its position in Albemarle Corporation (NYSE:ALB – Free Report) by 65.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,629 shares of the specialty chemicals company’s stock after selling 3,118 shares during the quarter. Wellington Shields & Co. LLC’s holdings in Albemarle were worth $230,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Nordea Investment Management AB purchased a new stake in Albemarle in the fourth quarter worth approximately $6,171,000. Altfest L J & Co. Inc. purchased a new stake in Albemarle in the fourth quarter worth approximately $1,055,000. Aegis Wealth Management LLC purchased a new stake in Albemarle in the third quarter worth approximately $324,000. Three Seasons Wealth LLC purchased a new stake in Albemarle in the fourth quarter worth approximately $873,000. Finally, J. Safra Sarasin Holding AG boosted its stake in Albemarle by 493.3% in the fourth quarter. J. Safra Sarasin Holding AG now owns 84,011 shares of the specialty chemicals company’s stock worth $11,883,000 after buying an additional 69,850 shares in the last quarter. Hedge funds and other institutional investors own 92.87% of the company’s stock.

Albemarle Stock Performance

Shares of ALB stock opened at $174.78 on Wednesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.21 and a current ratio of 2.07. Albemarle Corporation has a fifty-two week low of $53.70 and a fifty-two week high of $221.00. The stock has a 50 day moving average price of $183.04 and a two-hundred day moving average price of $162.50. The company has a market capitalization of $20.61 billion, a P/E ratio of -51.25, a PEG ratio of 0.86 and a beta of 1.36.

Albemarle (NYSE:ALB – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The specialty chemicals company reported $2.95 earnings per share for the quarter, beating the consensus estimate of $1.24 by $1.71. Albemarle had a positive return on equity of 5.22% and a negative net margin of 5.00%.The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.34 billion. During the same quarter in the previous year, the company posted ($0.18) earnings per share. The business’s revenue was up 32.7% on a year-over-year basis. Analysts expect that Albemarle Corporation will post 12.45 earnings per share for the current year.

Albemarle Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Friday, June 12th will be given a $0.405 dividend. The ex-dividend date is Friday, June 12th. This represents a $1.62 annualized dividend and a yield of 0.9%. Albemarle’s payout ratio is presently -47.51%.

Wall Street Analyst Weigh In

Several analysts have issued reports on ALB shares. Truist Financial upped their target price on Albemarle from $245.00 to $260.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Zacks Research raised Albemarle from a “hold” rating to a “strong-buy” rating in a research note on Monday, May 11th. Scotiabank upped their target price on Albemarle from $200.00 to $215.00 and gave the stock an “outperform” rating in a research note on Thursday, May 14th. Rothschild & Co Redburn downgraded Albemarle from a “buy” rating to a “neutral” rating and set a $188.00 price objective for the company. in a research report on Wednesday, April 22nd. Finally, JPMorgan Chase & Co. lowered their price objective on Albemarle from $195.00 to $145.00 and set a “neutral” rating for the company in a research report on Friday, February 13th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $201.42.

Read Our Latest Research Report on Albemarle

Insiders Place Their Bets

In related news, CEO J Kent Masters sold 16,393 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $183.72, for a total transaction of $3,011,721.96. Following the completion of the transaction, the chief executive officer owned 87,519 shares in the company, valued at $16,078,990.68. This represents a 15.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.42% of the company’s stock.

Albemarle Profile

(Free Report)

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.